Et siis eel- ja pikapäevakauplemine? Või siis ka eel- ja pikapäevaturg?
FT kirjutab, et 2013. aasta juunis võib Inglismaa keskpanga järgmiseks juhiks saada Kanada keskpanga praegune juht Mark Carney.
One of the world’s most respected central bankers, Mr Carney, 47, now heads the Financial Stability Board, which oversees global financial regulation. He was approached recently by a member of the BoE’s court, the largely non-executive body that oversees its activities, according to three people involved in the process.
While Paul Tucker, the BoE’s current deputy governor for financial stability, remains the favourite to replace Sir Mervyn, there is a growing view within the Treasury that the BoE needs shaking up following its ponderous response to the financial crisis. Parachuting in an outsider for the first time in 30 years would signal the government’s intent that the central bank should stop acting solely as a monetary authority and take its financial stability role more seriously.
William Blair tõstab täna AIG (American International Group ) reitingu Hoia pealt Osta peale.
Analüütikud usuvad, et järgmise 12-18 kuu jooksul peaks AIG aktsiahind tõusma, kuna finantsiline paindlikkus ja kasumiteenimise võime kasvab. Seetõttu usuvad analüütikud, et antud eeldus pole veel aktsiahinda sisse arvestatud ja aktsia hind tõuseb märkimisväärselt, kui see avastatakse. Analüütikute hinnagul on ettevõtte raamatupidamuslik väärtus võib kasvada $ 55 taseme kanti ja järgmise aasta jooksul edasi juba $ 62-67 vahemikku.
Ühtlasi tõstavad nad ka esimese kvartali prognoose.
Summary: We are upgrading shares of American International Group to Outperform from Market Perform. We believe that the company should continue to unlock significant value over the next 12 to 18 months. The realization of value will provide increased financial flexibility and ultimately the ability to generate higher earnings. We believe this value is not currently reflected in the share price and the stock has significant upside as it becomes more apparent. Our forecast suggests that book value per share has the potential to grow from $55 to a range of $62‐$67 in the next 12 months.
While the shares have had a good run, the stock is trading at 52% of our projected 12‐month book value.
Even at the bottom end of the peer range (current average of 90%), the company should trade closer to 70%‐75% of book value, in our view.
Earnings Revisions: The first quarter should show evidence of greater value. We are increasing our first quarter 2012 earnings per share estimate from $0.65 to $1.92, primarily because of a reduction in share count and one‐time gains from AIA, Maiden Lane 2, and Maiden Lane 3. In addition, core insurance earnings should have a strong
showing. Our 2012 EPS estimate increased from $2.32 to $3.93 and our 2013 operating EPS estimate increased from $2.71 to $3.35. The 2013 EPS increase is due to an increased level of projected share buybacks.
Reduced Complexity. The company is strategically selling noncore assets to satisfy obligations with the government and shift its focus to its core operations. We see this as positive for AIG’s stock since the reduced complexity will increase investor interest. With AIG’s efforts more focused on its core operations, operating efficiency and profitability should improve as well.
Share Buybacks. As AIG sells its noncore assets, it will have excess cash that can be used for share buybacks. AIG in the first quarter repurchased 103.5 million shares from the U.S. Treasury at a price of $29 per share. We project share buybacks of $11.6 billion in 2012 and $6.8 billion in 2013, resulting in share reductions of 360 million and 160 million, respectively. With AIG’s stock trading well below book value, any share
repurchases will immediately be accretive to book value per share.
Analüütikud juhivad tähelepanu ka asjaolule, et AIG on oma tegevust muutmas strateegilselt läbipaistvamaks ja konkreetsemaks, kuna firma müüb oma vähem olulisi varasid, rahuldamaks valitsuse nõudeid ja keskendub üha enam oma põhitegevusele. Varade müügist peaks analüütikute hinnagul jätkuma ka aktsiate tagasiostuks.
AIG on viimasel ajal saanud positiivset toetust juba mitme analüüsimaja käest ja viimane neist (Wells Fargo upgrade) sattus 10. aprillil päevale, kui turul leidis aset korralik langus. Kui turg vähegi täna toetab, siis võiks AIG ka ostuhuvi näha. Antud calli oht on see, et aktsia on teinud läbi juba märkimisväärse tõusu.
Eelturul kaupleb aktsia $ 33,22 juures, 1,5% plusspoolel.
Analüütikud usuvad, et järgmise 12-18 kuu jooksul peaks AIG aktsiahind tõusma, kuna finantsiline paindlikkus ja kasumiteenimise võime kasvab. Seetõttu usuvad analüütikud, et antud eeldus pole veel aktsiahinda sisse arvestatud ja aktsia hind tõuseb märkimisväärselt, kui see avastatakse. Analüütikute hinnagul on ettevõtte raamatupidamuslik väärtus võib kasvada $ 55 taseme kanti ja järgmise aasta jooksul edasi juba $ 62-67 vahemikku.
Ühtlasi tõstavad nad ka esimese kvartali prognoose.
Summary: We are upgrading shares of American International Group to Outperform from Market Perform. We believe that the company should continue to unlock significant value over the next 12 to 18 months. The realization of value will provide increased financial flexibility and ultimately the ability to generate higher earnings. We believe this value is not currently reflected in the share price and the stock has significant upside as it becomes more apparent. Our forecast suggests that book value per share has the potential to grow from $55 to a range of $62‐$67 in the next 12 months.
While the shares have had a good run, the stock is trading at 52% of our projected 12‐month book value.
Even at the bottom end of the peer range (current average of 90%), the company should trade closer to 70%‐75% of book value, in our view.
Earnings Revisions: The first quarter should show evidence of greater value. We are increasing our first quarter 2012 earnings per share estimate from $0.65 to $1.92, primarily because of a reduction in share count and one‐time gains from AIA, Maiden Lane 2, and Maiden Lane 3. In addition, core insurance earnings should have a strong
showing. Our 2012 EPS estimate increased from $2.32 to $3.93 and our 2013 operating EPS estimate increased from $2.71 to $3.35. The 2013 EPS increase is due to an increased level of projected share buybacks.
Reduced Complexity. The company is strategically selling noncore assets to satisfy obligations with the government and shift its focus to its core operations. We see this as positive for AIG’s stock since the reduced complexity will increase investor interest. With AIG’s efforts more focused on its core operations, operating efficiency and profitability should improve as well.
Share Buybacks. As AIG sells its noncore assets, it will have excess cash that can be used for share buybacks. AIG in the first quarter repurchased 103.5 million shares from the U.S. Treasury at a price of $29 per share. We project share buybacks of $11.6 billion in 2012 and $6.8 billion in 2013, resulting in share reductions of 360 million and 160 million, respectively. With AIG’s stock trading well below book value, any share
repurchases will immediately be accretive to book value per share.
Analüütikud juhivad tähelepanu ka asjaolule, et AIG on oma tegevust muutmas strateegilselt läbipaistvamaks ja konkreetsemaks, kuna firma müüb oma vähem olulisi varasid, rahuldamaks valitsuse nõudeid ja keskendub üha enam oma põhitegevusele. Varade müügist peaks analüütikute hinnagul jätkuma ka aktsiate tagasiostuks.
AIG on viimasel ajal saanud positiivset toetust juba mitme analüüsimaja käest ja viimane neist (Wells Fargo upgrade) sattus 10. aprillil päevale, kui turul leidis aset korralik langus. Kui turg vähegi täna toetab, siis võiks AIG ka ostuhuvi näha. Antud calli oht on see, et aktsia on teinud läbi juba märkimisväärse tõusu.
Eelturul kaupleb aktsia $ 33,22 juures, 1,5% plusspoolel.
Gapping down
In reaction to disappointing earnings/guidance: IN -15.3%, CREE -6.9% (also downgraded to Hold from Buy at ThinkEquity), SYT -3% (light volume), ASML -2.8%, INTC -2.7%, IBM -2.2% (also downgraded to Neutral from Outperform at Macquarie), LLTC -1.7%.
M&A news: PARL -1.6% (ticking lower, Perfumania Holdings and Parlux Fragrances shareholders approve merger).
Select financial related names showing weakness: UBS -3%, NBG -2.8%, CS -2.6%, STD -2.3%, DB -1.2%, ING -0.4%, C -0.3%.
A few oil/gas related names showing modest weakness: E -1.3%, TOT -0.9%, RIG -0.6%, BP -0.4%.
Other news: GNW -9.1% (announces new timing for planned minority Initial Public Offering), TNP -6.8% (announces public offering of 10 mln shares common shares), ALU -4% (still checking, may be trading lower following ASML results), BEE -3.3% (plans to make a public offering of 16 million shares of its common stock), CHK -1.3% (Reuters discusses news that Chesapeake (CHK) CEO has borrowed $1.1 bln against his stakes in co's wells), BRK.B -0.9% (Warren Buffett has stage 1 prostate cancer), PNRA -0.8% (COO resigns).
Analyst comments: MSTR -1.5% (downgraded to Underweight from Equal Weight at First Analysis), FSLR -0.8% (downgraded to Sell from Hold at Wunderlich, upgraded to Hold at Cantor Fitzgerald).
In reaction to disappointing earnings/guidance: IN -15.3%, CREE -6.9% (also downgraded to Hold from Buy at ThinkEquity), SYT -3% (light volume), ASML -2.8%, INTC -2.7%, IBM -2.2% (also downgraded to Neutral from Outperform at Macquarie), LLTC -1.7%.
M&A news: PARL -1.6% (ticking lower, Perfumania Holdings and Parlux Fragrances shareholders approve merger).
Select financial related names showing weakness: UBS -3%, NBG -2.8%, CS -2.6%, STD -2.3%, DB -1.2%, ING -0.4%, C -0.3%.
A few oil/gas related names showing modest weakness: E -1.3%, TOT -0.9%, RIG -0.6%, BP -0.4%.
Other news: GNW -9.1% (announces new timing for planned minority Initial Public Offering), TNP -6.8% (announces public offering of 10 mln shares common shares), ALU -4% (still checking, may be trading lower following ASML results), BEE -3.3% (plans to make a public offering of 16 million shares of its common stock), CHK -1.3% (Reuters discusses news that Chesapeake (CHK) CEO has borrowed $1.1 bln against his stakes in co's wells), BRK.B -0.9% (Warren Buffett has stage 1 prostate cancer), PNRA -0.8% (COO resigns).
Analyst comments: MSTR -1.5% (downgraded to Underweight from Equal Weight at First Analysis), FSLR -0.8% (downgraded to Sell from Hold at Wunderlich, upgraded to Hold at Cantor Fitzgerald).
Gapping up
In reaction to strong earnings/guidance: THQI +44.4%, URI +10%, ISRG +6%, PII +5.3% (ticking higher), TXT +4%, CSX +3.3%, YHOO +3.3%, STX +3.1%, HAL +2%, ABT +1.3%, SYK +0.2%, (light volume).
M&A news: CHSI +34.9% and SXCI +12.1% (Catalyst Health Solutions to be acquired by SXCI for $81.02/share or $4.4 bln; both co's reaffirm FY2012 guidance; expected to be highly accretive to SXCI's Non-GAAP FY13 earnings).
A few mining stocks trading higher: BBL +1.7%, BHP +1.7%, RIO +1.3%, .
Other news: DEPO +6.7% (announces intent to file NDA for Serada for treatment of menopausal hot flashes), ADES +2.9% (announces relocation of corporate headquarters to accommodate growth), BBY +2.6% (Star Tribune discusses how recent issues at BBY may make it a takeover target), MUX +1.6% (McEwen Mining announces 1Q2012 San Jose Mine production and management additions).
Analyst comments: DECK +2.2% (upgraded to Neutral from Underperform at Sterne Agee), AIG +1.8% (upgraded to Outperform from Market Perform at William Blair).
In reaction to strong earnings/guidance: THQI +44.4%, URI +10%, ISRG +6%, PII +5.3% (ticking higher), TXT +4%, CSX +3.3%, YHOO +3.3%, STX +3.1%, HAL +2%, ABT +1.3%, SYK +0.2%, (light volume).
M&A news: CHSI +34.9% and SXCI +12.1% (Catalyst Health Solutions to be acquired by SXCI for $81.02/share or $4.4 bln; both co's reaffirm FY2012 guidance; expected to be highly accretive to SXCI's Non-GAAP FY13 earnings).
A few mining stocks trading higher: BBL +1.7%, BHP +1.7%, RIO +1.3%, .
Other news: DEPO +6.7% (announces intent to file NDA for Serada for treatment of menopausal hot flashes), ADES +2.9% (announces relocation of corporate headquarters to accommodate growth), BBY +2.6% (Star Tribune discusses how recent issues at BBY may make it a takeover target), MUX +1.6% (McEwen Mining announces 1Q2012 San Jose Mine production and management additions).
Analyst comments: DECK +2.2% (upgraded to Neutral from Underperform at Sterne Agee), AIG +1.8% (upgraded to Outperform from Market Perform at William Blair).
First Solar (FSLR) sai lisaks Cantor Fitzgeraldi upgradele ja Wunderlichi downgradele veel ühe reitingumuutuse suuremalt majalt. Nimelt tõstab Merrill Lynch FSLR Hoia pealt Osta peale koos $ 30 hinnasihiga.
Aktsia kaupleb eelturul $ 23,70 kandis, 3,4% plusspoolel.
Aktsia kaupleb eelturul $ 23,70 kandis, 3,4% plusspoolel.
Saksamaa müüs täna 4,21 miljardi euro eest 2-aastaseid võlakirju ja tulusus tuli rekordmadal 0,14% vs eelmise kuu oksjoni 0,31%.
In view of the apparent re-election of the incumbent directors of Illumina, Roche has decided not to extend its $51.00 cash tender offer for all of the shares of Illumina. The offer will expire at 6:00 p.m., New York City time, on April 20, 2012.
ILMN hetkel -7% @ 41 dollarit
ILMN hetkel -7% @ 41 dollarit
FSLR ja WLT long, mõlemad kaunis ilusad asjad mu meelest.
Kes on need investorid, kes ostavad Saksamaa 2-aastast võlga 0,14%pa? Kas panus on Euroliidu lagunemisest tekkivale kaosele?
ymeramees
FSLR ja WLT long, mõlemad kaunis ilusad asjad mu meelest.
fail
Kuldar1
Kes on need investorid, kes ostavad Saksamaa 2-aastast võlga 0,14%pa? Kas panus on Euroliidu lagunemisest tekkivale kaosele?
Võlakriisi eest otsitakse kaitset küll.
Analysts see the auction as a clear success for Germany, at a time when fears of a deepening eurozone crisis remain high. Michael Leister of DZ Bank said:Once again it tells the story that demand for safety remains in place.
while Richard McGuire of Rabobank argued:Investor demand for core paper remains firm, with the background threat of crisis tensions ratcheting yet higher underpinning an overriding desire for capital preservation.
AloV
Et siis eel- ja pikapäevakauplemine? Või siis ka eel- ja pikapäevaturg?
Eestis liigub ringi mingi lingvistide vennaskond, kelle igapäevatöö seisneb võõrsõnade muinasaegseks eestikeeleks konverteerimises, "laptop ->rüperaal" vist üks tuntumaid saavutusi. Võiks koguda kokku olulisemad terminid ja anda neile töösse. Pakun, et lisaks "Pre ja after marketile" oleks hädasti vaja vasteid järgnevatele sõnadele: "guido", "headlines crossing", ... jne
Rüperaal on selle kõrval nohu. Värat ja düüler on hulga seksikamad. On jadavärat ja on rööpvärat. Samuti on mitmiktegursüsteemid. Mingid roppudsed on veel, aga kohe kõik ei meenu. Lüümik on tore juhet kokku laskev sõna.
guido = hinnang / hinnangu andmine
headline crossing = esiuudis / esiuudistes
guido = hinnang / hinnangu andmine
headline crossing = esiuudis / esiuudistes
AIG oli täiesti lootusetu juhtum nagu ka kõik teised positiivsed callid täna. Aktsia avanes $ 33,12 ja peale avanemist tuli ka kohe alla ning nüüd on jäänud kauplema $ 32,60 kanti, 0,5% miinuspoolel.
QCOM Qualcomm prelim $1.01 vs $0.96 Capital IQ Consensus Estimate; revs $4.94 bln vs $4.81 bln Capital IQ Consensus Estimate
VMW VMware prelim $0.66 vs $0.59 Capital IQ Consensus Estimate; revs $1.06 bln vs $1.03 bln Capital IQ Consensus Estimate
Qualcomm raises FY12 to $3.61-3.76 from $3.55-3.75 vs $3.78 Capital IQ Consensus Estimate; sees revs $18.7-19.7 bln vs $19.40 bln Capital IQ Consensus Estimate
VMware sees FY12 revs $4.525-4.625 bln vs $4.56 bln Capital IQ Consensus Estimate
QCOM kauplemas 7% miinuspoolel, $ 62,60 kandis.
VMW 1% kõrgemal, $ 111,60 juures.
VMW VMware prelim $0.66 vs $0.59 Capital IQ Consensus Estimate; revs $1.06 bln vs $1.03 bln Capital IQ Consensus Estimate
Qualcomm raises FY12 to $3.61-3.76 from $3.55-3.75 vs $3.78 Capital IQ Consensus Estimate; sees revs $18.7-19.7 bln vs $19.40 bln Capital IQ Consensus Estimate
VMware sees FY12 revs $4.525-4.625 bln vs $4.56 bln Capital IQ Consensus Estimate
QCOM kauplemas 7% miinuspoolel, $ 62,60 kandis.
VMW 1% kõrgemal, $ 111,60 juures.
FFIV F5 Networks prelim $1.09 vs $1.07 Capital IQ Consensus Estimate; revs $339.6 mln vs $335.44 mln Capital IQ Consensus Estimate
AXP American Express prelim $1.07 vs $1.00 Capital IQ Consensus Estimate; revs $7.61 bln vs $7.57 bln Capital IQ Consensus Estimate
AXP American Express prelim $1.07 vs $1.00 Capital IQ Consensus Estimate; revs $7.61 bln vs $7.57 bln Capital IQ Consensus Estimate